换一批
换一批ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
作者：
Pearson, Andrew D. J. [1]
;
Scobie, Nicole [2]
;
Norga, Koenraad [3]
;
Ligas, Franca [4]
;
Chiodin, Davy [5]
;
Burke, Amos [6]
;
Minard-Colin, Veronique [7]
;
Adamson, Peter [8]
;
Marshall, Lynley V. [9]
;
Balakumaran, Arun [10]
;
Benettaib, Bouchra [11]
;
Bhargava, Pankaj [12]
;
Bollard, Catherine M. [13]
;
Bolotin, Ellen [14]
;
Bomken, Simon [15]
;
Buechner, Jochen [16]
;
Burkhardt, Birgit [17]
;
Caron, Hubert [18]
;
Copland, Christopher [19]
;
Demolis, Pierre [20]
;
Egorov, Anton [21]
;
Farhan, Mahdi [22]
;
Zugmaier, Gerhard [23]
;
Gross, Thomas [24]
;
Horton-Taylor, Danielle [25]
;
Klapper, Wolfram [26]
;
Lesa, Giovanni [27]
;
Marcus, Robert [28]
;
Miles, Rodney R. [29]
;
Nottage, Kerri [30]
;
Pacaud, Lida [31]
;
Ricafort, Rosanna [32]
;
Schrappe, Martin [33]
;
Sterba, Jaroslav [34]
;
Vezan, Remus [35]
;
Weiner, Susan [36]
;
Kim, Su Young [37]
;
Reaman, Gregory [38]
;
Vassal, Gilles
作者单位：
Merck & Co Inc, Kenilworth, NJ USA
[1]
Janssen Res & Dev, Titusville, NJ USA
[2]
Bristol Myers Squibb Pharma EEIG, Oncol Clin Dev, New Brunswick, NJ USA
[3]
Debiopharm Int SA, Lausanne, Switzerland
[4]
Paris Sud Univ, Gustave Roussy, Dept Clin Res, Paris, France
[5]
Childrens Cause Canc Advocacy, Washington, DC USA
[6]
Univ Klinikum Schleswig Holstein, Kiel, Germany
[7]
Paediat Oncol Reference Team, London, England
[8]
Novartis, E Hanover, NJ USA
[9]
Univ Hosp Munster, Pediat Hematol Oncol & BMT, Munster, Germany
[10]
Amgen Res, Munich, Germany
[11]
Zoe4life, Sullens, Switzerland
[12]
Celgene Corp, Summit, NJ USA
[13]
Univ Kiel, Kiel, Germany
[14]
Inst Gustave Roussy, Villejuif, France
[15]
Gilead Sci Int Ltd, Cambridge, England
[16]
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
[17]
European Med Agcy, Paediat Med Off, Prod Dev Sci Support Dept, London, England
[18]
Unite2cure, Basel, Switzerland
[19]
Univ Utah, Dept Pathol, Salt Lake City, UT USA
[20]
George Washington Univ, Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, Washington, DC USA
[21]
Oslo Univ Hosp, Dept Paediat Hematol & Oncol, Oslo, Norway
[22]
Acerta Pharma SF, San Francisco, CA USA
[23]
Bayer Healthcare, Whippany, NJ USA
[24]
Masaryk Univ, Sch Med, Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic
[25]
Hoffman La Roche Ltd, Basel, Switzerland
[26]
NCI, Centrer Global Hlth, NIH, Bethesda, MD 20892 USA
[27]
AbbVie Ltd, N Chicago, IL USA
[28]
Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[29]
ANSM, St Denis, Reunion, France
[30]
Addenbrookes Hosp Cambridge, Dept Paediat Haematol & Oncol, Cambridge, England
[31]
HCA Healthcare, London, England
[32]
Newcastle Univ, Northern Inst Canc Res, Wolfson Childhood Canc Res Ctr, Newcastle Upon Tyne, Tyne &
[33]
Ctr Therapeut Innovat Oncol, Servier, France
[34]
Univ Ziekenhuis Antwerpen, Antwerp, Belgium
[35]
Kite Pharma, Clin Dev, Los Angeles, CA USA
[36]
ACCELERATE, Tucson, AZ 85714 USA
[37]
Royal Marsden NHS Fdn Trust, Paediat Drug Dev, Children & Young Peoples Unit, London, England
[38]
发布时间
2020-04-10
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
